Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptualized as a continuum from bed bound (immobility) on one extreme to making excursions to distant locations on the other extreme. Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy that can lead to gradual loss of vision in the peripheral field and central vision. Older adults with POAG have an increased risk for motor vehicle collisions and falls. Moreover, existing studies suggest that patients with POAG exhibit more postural sway while standing as measured by a balance platform and also tend to walk more slowly than those who are normally sighted and free of ocular disease. While these disturbances likely influence mobility, there has been little research directly assessing the impact of POAG on mobility. This study will assess the impact of POAG on life space (one aspect of mobility) and will determine whether difficulties with life space are associated with difficulties experienced under conditions of dim lighting.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:

• Participants that are enrolled in the Early Detection of Glaucoma Progression using a Novel Individualized Approach (IRB-300000301) or in the African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the Lamina Cribrosa in Progression (IRB-161115004).

• No diagnosis of eye disease

Locations
United States
Alabama
University of Alabama Birmingham
RECRUITING
Birmingham
Contact Information
Primary
Lyne Racette, PhD
lracette@uabmc.edu
205-325-8673
Time Frame
Start Date: 2019-06-01
Estimated Completion Date: 2026-05-30
Participants
Target number of participants: 100
Treatments
Primary Open-Angle Glaucoma
Patients diagnosed with primary open-angle glaucoma.
Control
Participants with healthy eyes.
Sponsors
Leads: University of Alabama at Birmingham

This content was sourced from clinicaltrials.gov